LEGISLATION
KH
Oregon’s Drug Decriminalization Law Fails to Save Lives
The article examines the aftermath of Oregon’s Measure 110, which decriminalized personal quantities of drugs with the aim of redirecting funds toward addiction recovery services. There are many signs the law has failed to meet its objectives, with few individuals seeking help despite citations, increased crime and drug use, and a surge in fentanyl-related deaths. Now, the state has begun to shift its opinions and actions toward recriminalization.
Pharma Executives Now Face Jail Time for their Role in the Opioid Epidemic
News reports and Justice Department press releases show two prominent pharmaceutical company executives are facing jail time for their role in causing the opioid epidemic.
Recent Overdoses in New York Show How Drug Abuse can Harm People of All Backgrounds
When three New Yorkers of remarkably different backgrounds overdosed and died on the same day, many believed their deaths were coincidental. But investigators later began to see a pattern when they discovered that all three users had ordered drugs from the same dealer. The story that followed unveiled numerous warning signs, lessons that Americans must learn to prevent more overdose deaths.
Does Removing Criminal Penalties for Drug Use Lead to More Drug Use?
Does it really make sense to blanket legalize drugs? On the other hand, does it really make sense to continue the War on Drugs? Or is it possible that leaving some penalties in place but altering or lessening them if treatment is completed might be more effective than either blanket legalization of drugs or ruthlessly throwing people in jail for drug use?
New Developments in the Sackler Case Suggest More Needs to be Done to Hold Pharma Magnates Accountable
In the late-1990s and early-2000s, pharmaceutical manufacturers like Purdue Pharma aggressively marketed addictive drugs such as OxyContin, pushing doctors to prescribe them. Today, though it’s known that these companies helped create America’s opioid epidemic, the owners of the companies appear poised to escape accountability.
The Sackler Case Comes to a Close; Final Analysis and the Importance of Holding Pharma Companies Accountable
Consider this: Purdue Pharmaceuticals/the Sacklers versus thousands of plaintiffs nationwide. It was one of the most closely watched pharmaceutical litigations of our time, and it just came to a close. While there were some small victories in the case, many see its outcome as a loss for those who suffered at the hands of Purdue’s addictive opioid painkiller, OxyContin.
KH
Decriminalization Not a Silver Bullet For Americans
With Oregon being the first state to decriminalize all drugs, it’s time to look at how decriminalization can—or can’t—be done in a way that does NOT increase deaths resulting from drug abuse.
KH
U.S. States Request $2.2 TRILLION Compensation from Purdue to Address Opioid Harm
Forty-seven U.S. States have filed lawsuits against Purdue Pharma, requesting a total of $2.2 trillion dollars as compensation for Purdue’s contributions to the opioid epidemic. Is this a fair number?
Drug Court Vs. Treatment: How Drug Courts Can Help | Narconon
In a nation that struggles with a drug addiction epidemic, our society rapidly seeks solutions and methodology for reducing the drug problem.
Decriminalization, Legalization, or Diversion—What’s the Right Solution?
As our great nation continues to struggle with a sweeping drug problem, the American people have attempted to create new ways and means of addressing that problem. Not all such approaches have been successful or sensible.
NARCONON NEWS
Narconon Extends Hope to Africa with Grand Opening of Continental Center
Narconon Centers
•
Rustenburg, South Africa
Celebrating 56 Years of Saving Lives with the Narconon Program
News
•
International